1,420
Participants
Start Date
May 31, 2007
Primary Completion Date
March 31, 2008
Study Completion Date
March 31, 2008
Interferon beta-1b (Betaseron, BAY86-5046)
Phase A: 250ug administrated s.c. every other day (double blind). For patients previously randomized in Bayer study 91162 to the same treatment. Phase B: All patients will receive 500µg s.c.every other day (open-label).
Interferon beta-1b (Betaseron, BAY86-5046)
Phase A: 500ug administrated s.c. every other day (double blind). For patients previously randomized in Bayer study 91162 to the same treatment. Phase B: All patients will receive 500µg s.c.every other day (open-label).
Interferon beta-1b (Betaseron, BAY86-5046)
"Phase A: 250ug administrated s.c. every other day (open-label). For patients previously randomized in Bayer study 91162 to 20mg Copaxone® administrated s.c. once daily and patients with premature discontinuation of study medication during the study 91162.~Phase B: All patients will receive 500µg s.c.every other day (open-label)."
Dublin
Dublin
Budapest
Brussels
Budapest
Melsbroek
Maribor
Kogarah
Leuven
Bern
Parkville
Fitzroy
Miskolc
Linz
Nedlands
Innsbruck
Pécs
Aarhus
Graz
Sankt Gallen
Győr
Orbassano
Mineola
Athens
Stony Brook
Berlin
Berlin
Rochester
Pittsburgh
Hennigsdorf
Greifswald
Philadelphia
Newark
Washington D.C.
Hamburg
Milan
Hamburg
Dijon
Fairfax
Winston-Salem
Durham
Charlotte
Málaga
Charleston
Nîmes
Hanover
Hanover
Augusta
Haifa
Toulouse
Maitland
Bordeaux
Miami
Tampere
Tampa
Tampa
Rennes
Marburg
Cullman
Padua
Giessen
Göttingen
Nashville
Louisville
Düsseldorf
Katowice
Seville
Columbus
Nantes
Essen
Cincinnati
Indianapolis
Fort Wayne
Münster
Detroit
Florence
Des Moines
Wroclaw
Tel Litwinsky
Milwaukee
Nancy
Thessaloniki
Duluth
Lille
Chicago
Kharkiv
Poznan
Clermont-Ferrand
Offenbach
St Louis
Tel Aviv
Kansas City
Heidelberg
Bari
Ẕerifin
Shreveport
Houston
San Antonio
Ashkelon
Lviv
Fort Collins
Donetsk
Phoenix
Tucson
Henderson
Reno
Oulu
Lodz
Jerusalem
La Jolla
Regensburg
San Francisco
Berkeley
Bayreuth
Sacramento
Tualatin
Seattle
Tacoma
Moskva
Moskva
Moskva
Moskva
Moskva
Yaroslavl
Saint Petersburg
Saint Petersburg
Saint Petersburg
Nizhy Novgorod
Novosibirsk
Birmingham
Atlanta
Newark
Albuquerque
Providence
Buenos Aires
Buenos Aires
Buenos Aires
Córdoba
Rosario
Rosario
Dublin
Cork
Liverpool
Wyoming
Sankt Pölten
Curitiba
Recife
Rio de Janeiro
Porto Alegre
Campinas
São Paulo
São Paulo
São Paulo
Calgary
Vancouver
Halifax
London
Mississauga
Nepean
Ottawa
Toronto
Greenfield Park
Hull
Montreal
Montreal
Nice
Dresden
Leipzig
Halle
Zalaegerszeg-Pozva
Roma
Riga
Breda
Nijmegen
Sittard
Bergen
Gdansk
Warsaw
Warsaw
Ljubljana
L'Hospitalet de Llobregat
Stockholm
Uppsala
Kiev
Lead Sponsor
Bayer
INDUSTRY